Storskogen appoints Chris Pullen as permanent Managing Director of Storskogen UK

Storskogen has appointed Chris Pullen as Executive Vice President and permanent Managing Director of Storskogen UK after he led UK operations on an interim basis since May 2025. Pullen, an Investment Director since 2022 who chairs five of the group's business unit boards and has prior UK CEO experience (APCOA Parking UK, idverde UK, Staffline), is expected to bolster UK leadership and execution of the group’s buy-and-build strategy. The group reports roughly 11,000 employees and SEK 33 billion in net sales and is listed on Nasdaq Stockholm.

Analysis

Market structure: The appointment materially improves Storskogen’s ability to source and integrate UK add‑ons — direct beneficiaries include Storskogen (Nasdaq Stockholm) and UK SME vendors in services/maintenance niches; competitors without proven UK operating leads risk losing deal flow. Expect modest pricing power upside: a credible operational CEO could drive 100–300 bps EBIT margin expansion across UK units over 12–24 months, implying a 10–20% EPS swing if financed conservatively.

Risk assessment: Tail risks include failed integrations, a UK SME demand shock (UK GDP decline >1% could compress mid‑market multiples 15–30%) and adverse currency (GBP weakening >5% vs SEK reduces reported sales). Immediate impact (days) is likely muted; short term (3–12 months) watch for deal announcements and margin inflection; long term (2–5 years) value depends on execution cadence and leverage used in add‑ons.

Trade implications: Implement directional and relative trades: bias modest long in Storskogen equity sized 2–3% portfolio with a 12‑month target +12–18% and 8% stop; use 6–9 month call spreads (buy ATM, sell 25% OTM) to cap cost. Pair trade idea: long Storskogen vs short 3i Group (LSE:III) to express confidence in UK SME roll‑up execution versus larger PE cyclicality; horizon 6–12 months.

Contrarian angles: Consensus underweights execution drag and overestimates immediate rerating; market likely underprices the multi‑quarter integration costs (expect a potential 50–150 bps temporary EBIT drag). Historical parallels (EQT/other Nordic roll‑ups) show visible margin payback only after 12–24 months — if Storskogen reports two add‑ons within 90 days the market may materially reprice upwards, otherwise disappointment risk is significant.

Key Decisions for Investors

• Consider establishing a 2–3% long position in Storskogen (Nasdaq Stockholm) over the next 2–6 weeks to capture potential rerating; set a 12‑month target +12–18% and an 8% hard stop to limit execution risk.
• Implement a cost‑efficient 6–9 month call spread on Storskogen: buy ATM calls and sell 25% OTM calls sized to represent 1–1.5% of portfolio notional to participate in upside while capping premium outlay.
• Enter a pair trade: long Storskogen (2% portfolio) vs short 3i Group (LSE:III) sized to equal beta; hold 6–12 months and rebalance if Storskogen reports ≥2 UK add‑ons or shows ≥100 bps EBIT margin improvement.
• Reduce/avoid new buys in UK domestic SME services names with high cyclicality and currency exposure until Q2 UK deal flow and Storskogen’s UK integration KPIs are disclosed (monitor #add‑ons, consolidated EBITA margin, GBP/SEK moves over next 30–90 days).